𝔖 Bobbio Scriptorium
✦   LIBER   ✦

No predictive value of GC phenotypes for HIV infection and progression to AIDS

✍ Scribed by Jan C. Pronk; Rune R. Frants; Bart Crusius; Aldur W. Eriksson; Frank Wolf; Charles A. B. Boucher; Margreet Bakker; Jaap Goudsmit

Publisher
Springer
Year
1988
Tongue
English
Weight
234 KB
Volume
80
Category
Article
ISSN
0340-6717

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

A Markov model for HIV disease progressi
A Markov model for HIV disease progression including the effect of HIV diagnosis and treatment: Application to AIDS prediction in England and Wales
✍ Odd O. Aalen; Vernon T. Farewell; Daniela de Angelis; Nicholas E. Day; O. NΓΆel G πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 206 KB πŸ‘ 2 views

Back-calculation is a widely used method to estimate HIV incidence rates, and is commonly based on times of AIDS diagnosis. Following up earlier work, we extend this method to also incorporate knowledge of times of HIV diagnosis (first positive test). This is achieved through the use of a Markov mod

Progression towards AIDS leads to increa
Progression towards AIDS leads to increased torque teno virus and torque teno minivirus titers in tissues of HIV infected individuals
✍ K. Thom; J. Petrik πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 255 KB

## Abstract Torque teno virus (TTV) and Torque teno minivirus (TTMV) are highly prevalent in the general population and although no disease has been associated with these viruses yet, co‐infections with other pathological viruses are frequent. Both viruses are extremely heterogeneous, especially fo

Predictive value of drug levels, HIV gen
Predictive value of drug levels, HIV genotyping, and the genotypic inhibitory quotient (GIQ) on response to saquinavir/ritonavir in antiretroviral-experienced HIV-infected patients
✍ Luisa Valer; Carmen de Mendoza; Vincent Soriano πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 72 KB

Plasma levels of HIV protease inhibitors (PI) are often close to IC50 values of wild-type viruses when administered without ritonavir boosting. The impact of drug levels, resistance mutations, and the genotypic inhibitory quotient (GIQ) were examined on the response to saquinavir/ritonavir (SQV/r)-b